Arkolith/Insider Trading/APLT/Form 4

Shendelman Shoshana

President and CEO, Director, 10% OwnerApplied Therapeutics Inc. (APLT) · full profile →Form 4 · filed Dec 22, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 21, 2023Grant(A)440K—$04.1M
Dec 21, 2023Grant(A)1.1M—$03.7M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-059636) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML